NCT02673710 A Study to Assess the Impact of Sarcopenia on the Outcomes of Colorectal Cancer Patients Treated With Chemotherapy Combined With Bevacizumab Status COMPLETED Phase N/A
NCT02654639 Ph 2 Study of TAS-102 / Bevacizumab Maintenance Therapy Post Induction Chemotherapy in Metastatic Colorectal Cancer Status TERMINATED Phase PHASE2
NCT02641873 A Study of BBI608 Administrated With FOLFIRI + Bevacizumab in Adult Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE1
NCT02624895 ObservationaL Study on the Qol of RAS Wild-type mCRC Patients Receiving Anti-EGFR MAbs + FOLFOX or FOLFIRI as 1st Line Status COMPLETED Phase N/A
NCT02624726 Trial in Metastatic Colorectal Cancer With FOLFIRI Plus Aflibercept as First Line Treatment Status UNKNOWN Phase PHASE2
NCT02623621 Soluble Vascular Endothelial Growth Factor Receptor 2 as Predictor of Benefit From Bevacizumab Beyond Progression in Metastatic Colorectal Cancer Status COMPLETED Phase N/A
NCT02615574 A Study of Type-1 Polarized Dendritic Cell (αDC1) Vaccine in Combination With Tumor-Selective Chemokine Modulation (Interferon-α2b, Rintatolimod, and Celecoxib) in Subjects With Chemo-Refractory Metastatic Colorectal Cancer Status WITHDRAWN Phase PHASE2
NCT02612077 Observation of Patients With Metastatic Colorectal Cancer Starting Chemotherapy Combined With Bevacizumab (Avastin) Status COMPLETED Phase N/A
NCT02611661 Local Ablative Strategies After Endovascular Radioembolization Status TERMINATED Phase PHASE1
NCT02605044 Masitinib in Combination With FOLFIRI for Second-line Treatment of Patients With Metastatic Colorectal Cancer Status TERMINATED Phase PHASE3
NCT02597075 Physical Activity in Patients With Metastatic Colorectal Cancer Who Receive Palliative First-line Chemotherapy Status TERMINATED Phase NA
NCT02575378 Maintenance Treatment With Capecitabine Metronomic Chemotherapy and Chinese Traditional Medicine in Metastatic Colorectal Cancer Status UNKNOWN Phase PHASE4
NCT02568046 Sym004 in Combination With FOLFIRI in Metastatic Colorectal Cancer Patients Status TERMINATED Phase PHASE1/PHASE2
NCT02542436 Avastin (Bevacizumab) in the Treatment of Metastatic Colorectal Cancer in Normal Clinical Use in the UK Population Status WITHDRAWN Phase N/A
NCT02511756 Visualization of Anti-angiogenic Effects With Perfusion Computed Tomography (CTP) Status TERMINATED Phase NA
NCT02503150 Trial of Antigen Pulsed Dendritic Cells (APDC) in Metastatic Colorectal Cancer Status UNKNOWN Phase PHASE3